Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 32,595 shares at $165.01 ($5.4M) on 2001-10-03, disclosed to the SEC on 2018-10-05.
Open-market sale of $5.4M LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.01 | 2,905 | $479K | 8.9% |
| 2 | $165.01 | 2,905 | $479K | 8.9% |
| 3 | $165.95 | 1,225 | $203K | 3.8% |
| 4 | $165.95 | 1,225 | $203K | 3.8% |
| 5 | $167.09 | 673 | $112K | 2.1% |
| 6 | $167.09 | 673 |
| $112K |
| 2.1% |
| 7 | $168.29 | 1,297 | $218K | 4.1% |
| 8 | $168.29 | 1,297 | $218K | 4.1% |
| 9 | $169.00 | 3,705 | $626K | 11.7% |
| 10 | $169.68 | 195 | $33K | 0.6% |
| 11 | $169.68 | 195 | $33K | 0.6% |
| 12 | $160.61 | 1,700 | $273K | 5.1% |
| 13 | $161.41 | 1,553 | $251K | 4.7% |
| 14 | $161.41 | 1,553 | $251K | 4.7% |
| 15 | $162.60 | 3,152 | $513K | 9.5% |
| 16 | $162.60 | 3,152 | $513K | 9.5% |
| 17 | $163.64 | 2,000 | $327K | 6.1% |
| 18 | $164.59 | 1,395 | $230K | 4.3% |
| 19 | $164.59 | 1,395 | $230K | 4.3% |
| 20 | $165.57 | 200 | $33K | 0.6% |
| 21 | $165.57 | 200 | $33K | 0.6% |
| Total | $164.79 avg | 32,595 | $5.4M | 100% |
| Filing → |
| LOXO | SELL | 2018-11-28 | $2.9M | — | Filing → |
| LOXO | SELL | 2018-09-14 | $5.0M | — | Filing → |
| LOXO | SELL | 2018-08-15 | $4.6M | — | Filing → |